|  |  |  |
| Protein Variant Possible Key to Cancer Drug Resistance (Newswise) |
| Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the cancer-killing drug. |
| |
|
|  |
 | |  |
| | |
|
